SOLACI-CACI 2021 | Innovation in Interventional Cardiovascular and Endovascular Medicine

✔️ Watch again the Session “Innovation in Interventional Cardiovascular and Endovascular Medicine” in the SOLACI-CACI 2021 Congress.

👨‍🏫 Contenidos:

  • 05:14 – Digital Health Era. A digital (r)evolution. Digital tech medicine parade, the rapid technological innovations of the digital age – Chaim Lotan
  • 32:24 – The Best innovation in Structural, Coronary, Interventional suite, Hemodinamic Support in Interventional Heart Failure – Juan Granada
  • 01:02:41 – The Impact of Regenerative versus Prosthetic Approaches in Cardiovascular Therapy – Julio Palmaz
  • 01:24:31 – Expandable Endoprotesis, the solution – Juan Parodi

👉🏻 Panelists: -Abizaid, Alexandre – Bär, Nora – Rizzo, Marcela
👉🏻 Chairpersons: David Vetcher, Alberto Hendler & José Luis Leiva Pons

– Acceda a todos los videos del Congreso SOLACI-CACI 2021: https://bit.ly/3BG0LVb

Filmación realizada el 06/08/2021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | Complex Pulmonary Hypertension and Aortic Endovascular Aneurysm Session

✔️ Watch again the Session on "Complex Pulmonary Hypertension and Aortic Endovascular Aneurysm" in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: SESSION I: Chronic Thromboembolic...

SOLACI-CACI 2021 | Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease

✔️ Watch again the session "Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease" in the SOLACI-CACI 2021 Congress. 👨‍🏫...

SOLACI-CACI 2021 | Cardiovascular Disease Management and Cath Lab During the COVID-19 Pandemic

✔️ Watch again the session on Cardiovascular Disease Management and Cath Lab During the COVID-19 Pandemic in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 04:55 -...

SOLACI-CACI 2021 | DAPT Session

✔️ Watch again the DAPT Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 02:58 - Short versus long-term DAPT Therapy in High Risk Bleeding. Rationality...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...